Hudson Value Partners, LLC Eli Lilly & CO Transaction History

Hudson Value Partners, LLC

$247 Million
Q3 2024

A detailed history of Hudson Value Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Hudson Value Partners, LLC holds 1,372 shares of LLY stock, worth $1.09 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

1,372

Previous 1,387 1.08%

Holding current value

$1.09 Million

Previous $1.26 Million 3.19%

% of portfolio

0.49%

Previous 0.55%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$772.14 - $960.02 $11,582 - $14,400	-15 Reduced 1.08%	1,372 $1.22 Million
Q2 2024 Jul 29, 2024	SELL	$724.87 - $909.04 $20,296 - $25,453	-28 Reduced 1.98%	1,387 $1.26 Million
Q1 2024 May 08, 2024	SELL	$592.2 - $792.28 $13,620 - $18,222	-23 Reduced 1.6%	1,415 $1.1 Million
Q4 2023 Feb 09, 2024	SELL	$525.19 - $619.13 $15,755 - $18,573	-30 Reduced 2.04%	1,438 $838,000
Q3 2023 Nov 02, 2023	SELL	$434.7 - $599.3 $3,042 - $4,195	-7 Reduced 0.47%	1,468 $788,000
Q2 2023 Aug 02, 2023	SELL	$350.74 - $468.98 $56,118 - $75,036	-160 Reduced 9.79%	1,475 $691,000
Q1 2023 May 09, 2023	BUY	$310.63 - $364.82 $11,803 - $13,863	38 Added 2.38%	1,635 $561,000
Q4 2022 Jan 27, 2023	SELL	$321.55 - $374.67 $32,155 - $37,467	-100 Reduced 5.89%	1,597 $584,000
Q3 2022 Nov 07, 2022	SELL	$296.48 - $337.87 $5,040 - $5,743	-17 Reduced 0.99%	1,697 $549,000
Q2 2022 Jul 29, 2022	SELL	$278.73 - $327.27 $62,435 - $73,308	-224 Reduced 11.56%	1,714 $556,000
Q1 2022 Apr 14, 2022	BUY	$234.69 - $291.66 $938 - $1,166	4 Added 0.21%	1,938 $555,000
Q4 2021 Jan 19, 2022	BUY	$224.85 - $279.04 $67,455 - $83,712	300 Added 18.36%	1,934 $534,000
Q1 2021 Apr 19, 2021	SELL	$164.32 - $212.72 $19,882 - $25,739	-121 Reduced 6.89%	1,634 $305,000
Q4 2020 Feb 18, 2021	BUY	$130.46 - $172.63 $228,957 - $302,965	1,755 New	1,755 $293,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Value Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Value Partners, LLC with notifications on news.

Account

Hudson Value Partners, LLC Eli Lilly & CO Transaction History